Briota’s SpiroPRO™ is India’s first CDSCO approved handheld digital spirometer powered with ML based on demographics data specially collected from Indian patients. Briota has now repositioned its Respiratory Disease Management system into the COVID-19 Early Warning (VIEW) system to monitor, stratify and manage High Risk Comorbid Patients.
What pain-point does it solve?
Co-Morbid patients cannot visit the hospital frequently for monitoring their condition because of high risk of infection by COVID-19.
Who are the ideal users of our technology?
Municipalities for home monitoring of COVID patients, Quarantine centers, hospitals
How does it solve the pain-point?
Briota is using AI and IoT technology for monitoring elderly and comorbid patients for their health condition. Briota’s VIEW Home monitoring and Remote Support for Comorbid COVID-19 positive or COVID-19 high risk patients performs patient stratification for early medical intervention. This will eventually help reduce the case fatality rate of COVID-19.
The Spirometer test can be performed with the help of a mobile software application which walks you through the process. Additional parameters such as for pneumonia, ventilation, respiratory rate, temperature, blood pressure, lung functioning etc. can be assessed.
What makes us stand apart from competitors ?
Briota’s COVID-19 Early Warning (VIEW) system helps monitor and manage high risk comorbid patients. The VIEW score is based on a sophisticated clinical algorithm which will mature and become more accurate as system start collecting more and more data of COVID-19 patients. Low cost and made in India.
The story of our successful deployments
Deployed with over three adopters
If you have any queries, please don’t hesitate to get in touch.
We are looking forward to hearing from you.